Published in Proc Natl Acad Sci U S A on March 01, 1985
Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35
Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev (1989) 7.80
A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity. J Exp Med (1992) 4.60
Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci U S A (1988) 3.82
Size variation of the M protein in group A streptococci. J Exp Med (1985) 3.45
Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci. Proc Natl Acad Sci U S A (1987) 2.90
Conversion of an M- group A streptococcus to M+ by transfer of a plasmid containing an M6 gene. J Exp Med (1986) 2.89
Environmental regulation of virulence in group A streptococci: transcription of the gene encoding M protein is stimulated by carbon dioxide. J Bacteriol (1992) 2.66
Expression of protein F, the fibronectin-binding protein of Streptococcus pyogenes JRS4, in heterologous streptococcal and enterococcal strains promotes their adherence to respiratory epithelial cells. Infect Immun (1992) 2.51
The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc Natl Acad Sci U S A (1994) 2.22
Role of M protein in adherence of group A streptococci. Infect Immun (1991) 2.05
Differential recognition of surface proteins in Streptococcus pyogenes by two sortase gene homologs. J Bacteriol (2002) 1.88
Homologous regions within M protein genes in group A streptococci of different serotypes. Infect Immun (1986) 1.85
Identification of an endogenous membrane anchor-cleaving enzyme for group A streptococcal M protein. Its implication for the attachment of surface proteins in gram-positive bacteria. J Exp Med (1989) 1.77
Group G streptococcal M protein exhibits structural features analogous to those of class I M protein of group A streptococci. Infect Immun (1992) 1.68
Spontaneous M6 protein size mutants of group A streptococci display variation in antigenic and opsonogenic epitopes. Proc Natl Acad Sci U S A (1988) 1.62
Nucleotide sequences of two adjacent M or M-like protein genes of group A streptococci: different RNA transcript levels and identification of a unique immunoglobulin A-binding protein. Infect Immun (1992) 1.53
A highly conserved region present in transcripts encoding heterologous M proteins of group A streptococci. Infect Immun (1987) 1.40
Biological and immunochemical identity of M protein on group G streptococci with M protein on group A streptococci. Infect Immun (1987) 1.39
Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010. Emerg Infect Dis (2011) 1.32
M proteins of group G streptococci isolated from bacteremic human infections. Infect Immun (1987) 1.24
Architecture of the vir regulons of group A streptococci parallels opacity factor phenotype and M protein class. J Bacteriol (1992) 1.22
Genomic analysis of emm59 group A Streptococcus invasive strains, United States. Emerg Infect Dis (2012) 1.10
Molecular analysis of the M protein of Streptococcus equi and cloning and expression of the M protein gene in Escherichia coli. Infect Immun (1987) 0.97
Deriving group A Streptococcus typing information from short-read whole-genome sequencing data. J Clin Microbiol (2014) 0.95
High Incidence of Invasive Group A Streptococcus Disease Caused by Strains of Uncommon emm Types in Thunder Bay, Ontario, Canada. J Clin Microbiol (2015) 0.95
Protective and heart-crossreactive epitopes located within the NH2 terminus of type 19 streptococcal M protein. J Exp Med (1988) 0.93
Integrated whole-genome sequencing and temporospatial analysis of a continuing Group A Streptococcus epidemic. Emerg Microbes Infect (2013) 0.87
Expression of streptococcal M protein in mammalian cells. Proc Natl Acad Sci U S A (1988) 0.85
Evidence for actinlike proteins in an M protein-negative strain of Streptococcus pyogenes. Infect Immun (1992) 0.81
Ultrastructural localization of the fibrinogen-binding domain of streptococcal M protein. Infect Immun (1989) 0.80
Rapid Emergence of a New Clone Impacts the Population at Risk and Increases the Incidence of Type emm89 Group A Streptococcus Invasive Disease. Open Forum Infect Dis (2017) 0.75
Emergence of Streptococcus pyogenes emm102 causing toxic shock syndrome in Southern Taiwan during 2005-2012. PLoS One (2013) 0.75
Phosphorylase-cross-reactive antibodies evoked by streptococcal M protein. Infect Immun (1990) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene (1977) 114.87
The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene (1982) 102.30
"A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. Anal Biochem (1984) 66.58
A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments. Gene (1982) 59.01
Determination of nucleic acid sequence homologies and relative concentrations by a dot hybridization procedure. Nucleic Acids Res (1979) 21.96
Hybridization of nucleic acids immobilized on solid supports. Anal Biochem (1984) 17.32
Current knowledge of type-specific M antigens of group A streptococci. J Immunol (1962) 14.71
The arrangement of simian virus 40 sequences in the DNA of transformed cells. Cell (1976) 12.60
A general method for the isolation of RNA complementary to DNA. Proc Natl Acad Sci U S A (1962) 8.21
Pilus expression in Neisseria gonorrhoeae involves chromosomal rearrangement. Cell (1982) 7.19
Electron microscopic studies on streptococci. I. M antigen. J Exp Med (1969) 6.77
Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci U S A (1981) 5.56
Persistence of type-specific antibodies in man following infection with group A streptococci. J Exp Med (1959) 5.02
Studies on the chemical structure of the streptococcal cell wall. II. The composition of group C cell walls and chemical basis for serologic specificity of the carbohydrate moiety. J Exp Med (1962) 5.00
Reduction in the rate of DNA reassociation by sequence divergence. J Mol Biol (1973) 4.94
IMMUNOLOGIC RELATION OF STREPTOCOCCAL AND TISSUE ANTIGENS. I. PROPERTIES OF AN ANTIGEN IN CERTAIN STRAINS OF GROUP A STREPTOCOCCI EXHIBITING AN IMMUNOLOGIC CROSS-REACTION WITH HUMAN HEART TISSUE. J Immunol (1963) 4.05
Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein. J Exp Med (1984) 3.69
Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart. J Exp Med (1982) 2.84
Purification and physical properties of group C streptococcal phage-associated lysin. J Exp Med (1971) 2.67
Expression of streptococcal M protein in Escherichia coli. Science (1983) 2.57
The complete amino acid sequence of a biologically active 197-residue fragment of M protein isolated from type 5 group A streptococci. J Biol Chem (1984) 2.40
The presence of type 12 M-protein antigen in group G streptococci. J Gen Microbiol (1967) 2.20
Antigenicity of the M proteins of group A hemolytic streptococci. IV. Cross-reactivity between serotypes. J Immunol (1968) 2.18
Streptococcal M protein extracted by nonionic detergent. II. Analysis of the antibody response to the multiple antigenic determinants of the M-protein molecule. J Exp Med (1977) 2.13
Infections due to group C streptococci in man. Am J Med (1979) 2.08
Group G streptococcal bacteremia: clinical study and review of the literature. Rev Infect Dis (1983) 2.00
Heterogeneity of type-specific and cross-reactive antigenic determinants within a single M protein of group A streptococci. J Exp Med (1980) 2.00
Serious infections due to group G streptoccocci. Report of 15 cases with in vitro-in vivo correlations. Am J Med (1983) 1.57
Purification and antigenicity of an M-like protein of Streptococcus equi. Infect Immun (1974) 1.39
Rheumatic heart disease unabated in developing countries. Lancet (1981) 1.38
Cross-reactions among group A streptococci. II. Further analysis of antigens related to type-specificity and protection. J Immunol (1969) 1.28
Variation in the M-antigen of group-A streptococci. J Med Microbiol (1969) 1.12
Unusual occurrence of neonatal septicemia due to group G streptococcus. Pediatrics (1974) 0.97
Group G streptococcal pneumonia and sepsis in a newborn infant. J Clin Microbiol (1979) 0.93
Evidence for positive regulation of plasmid prophage P1 replication: integrative suppression by copy mutants. J Bacteriol (1983) 0.91
The capsule of Streptococcus equi. J Gen Microbiol (1974) 0.80
Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science (2001) 21.99
Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc Natl Acad Sci U S A (1992) 6.95
Sorting of protein A to the staphylococcal cell wall. Cell (1992) 6.48
Complete nucleotide sequence of type 6 M protein of the group A Streptococcus. Repetitive structure and membrane anchor. J Biol Chem (1986) 6.38
Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci U S A (1981) 5.56
Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems. J Bacteriol (1991) 4.99
A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity. J Exp Med (1992) 4.60
A method to isolate RNA from gram-positive bacteria and mycobacteria. Anal Biochem (1994) 4.24
Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat Med (2001) 4.09
Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci U S A (1988) 3.82
A response regulator that represses transcription of several virulence operons in the group A streptococcus. J Bacteriol (1999) 3.81
An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: use of a temperature-sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes. Mol Microbiol (1993) 3.76
Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science (2001) 3.72
Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein. J Exp Med (1984) 3.69
Phage Pl cryptic. II. Location and regulation of prophage genes. Virology (1973) 3.63
Regulation of plasmid replication. Microbiol Rev (1984) 3.55
Size variation of the M protein in group A streptococci. J Exp Med (1985) 3.45
alpha-enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci. J Biol Chem (1998) 3.37
Genetic manipulation of pathogenic streptococci. Methods Enzymol (1991) 3.34
Size variation in group A streptococcal M protein is generated by homologous recombination between intragenic repeats. Mol Gen Genet (1987) 3.32
Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein. J Exp Med (1985) 3.23
Variation in the expression of cell wall proteins of Staphylococcus aureus grown on solid and liquid media. Infect Immun (1988) 3.21
Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci U S A (2001) 3.10
The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect Immun (1999) 2.94
Excision and insertion of the conjugative transposon Tn916 involves a novel recombination mechanism. Cell (1989) 2.91
Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci. Proc Natl Acad Sci U S A (1987) 2.90
Conversion of an M- group A streptococcus to M+ by transfer of a plasmid containing an M6 gene. J Exp Med (1986) 2.89
Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect Immun (2000) 2.84
Streptococcal M protein extracted by nonionic detergent. I. Properties of the antiphagocytic and type-specific molecules. J Exp Med (1976) 2.77
Tropomyosin-like seven residue periodicity in three immunologically distinct streptococal M proteins and its implications for the antiphagocytic property of the molecule. J Exp Med (1980) 2.75
Purification and physical properties of group C streptococcal phage-associated lysin. J Exp Med (1971) 2.67
Environmental regulation of virulence in group A streptococci: transcription of the gene encoding M protein is stimulated by carbon dioxide. J Bacteriol (1992) 2.66
Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae. Infect Immun (2000) 2.64
Studies on group A streptococcal M-proteins: purification of type 5 M-protein and comparison of its amino terminal sequence with two immunologically unrelated M-protein molecules. J Immunol (1980) 2.62
A plasmid-encoded regulatory gene, rns, required for expression of the CS1 and CS2 adhesins of enterotoxigenic Escherichia coli. Proc Natl Acad Sci U S A (1989) 2.62
Expression of streptococcal M protein in Escherichia coli. Science (1983) 2.57
Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J Infect Dis (2000) 2.55
A turbid plaque-forming mutant of phage P1 that cannot lysogenize Escherichia coli. Virology (1974) 2.47
TUBERCULOSIS OF THE APPENDIX. Ann Surg (1917) 2.44
Genetic studies on bacteriophage P1. Virology (1968) 2.43
The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci. J Exp Med (1988) 2.42
The complete amino acid sequence of a biologically active 197-residue fragment of M protein isolated from type 5 group A streptococci. J Biol Chem (1984) 2.40
Isolation and characterization of the cell-associated region of group A streptococcal M6 protein. J Bacteriol (1988) 2.35
Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect Immun (1988) 2.24
Role of mga in growth phase regulation of virulence genes of the group A streptococcus. J Bacteriol (1997) 2.20
Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J Exp Med (1989) 2.15
Streptococcal M protein extracted by nonionic detergent. II. Analysis of the antibody response to the multiple antigenic determinants of the M-protein molecule. J Exp Med (1977) 2.13
Is vaginal birth after cesarean less expensive than repeat cesarean delivery? Am J Obstet Gynecol (2000) 2.09
Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine (2000) 2.07
Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin Microbiol Rev (1998) 2.06
Genetic correlates of throat and skin isolates of group A streptococci. J Infect Dis (1996) 2.06
Role of M protein in adherence of group A streptococci. Infect Immun (1991) 2.05
Obstetric complications associated with the lupus anticoagulant. N Engl J Med (1985) 2.05
Immunochemical localization and amino acid sequences of crossreactive epitopes within the group A streptococcal M6 protein. J Exp Med (1986) 2.03
A comparison of meta-analytic results using literature vs individual patient data. Paternal cell immunization for recurrent miscarriage. JAMA (1995) 2.02
Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science (1998) 2.02
Pharmaceutical history and its sources in the Wellcome collections. 3. Fluid medicines, prescription reform and posology 1700-1900. Med Hist (1970) 2.01
Use of the lactococcal nisA promoter to regulate gene expression in gram-positive bacteria: comparison of induction level and promoter strength. Appl Environ Microbiol (1998) 1.96
Expression of the Arp protein, a member of the M protein family, is not sufficient to inhibit phagocytosis of Streptococcus pyogenes. Infect Immun (1995) 1.95
Characterization and biological properties of a new staphylococcal exotoxin. J Exp Med (1994) 1.91
DNA sequence of the serum opacity factor of group A streptococci: identification of a fibronectin-binding repeat domain. Infect Immun (1995) 1.91
Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J Immunol (1995) 1.89
Homologous regions within M protein genes in group A streptococci of different serotypes. Infect Immun (1986) 1.85
Integration of the plasmid prophages P1 and P7 into the chromosome of Escherichia coli. J Mol Biol (1979) 1.83
Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc Natl Acad Sci U S A (1995) 1.80
Effect of psychoprophylaxis (Lamaze preparation) on labor and delivery in primiparas. N Engl J Med (1976) 1.80
Requirements for the opsonic activity of human IgG directed to type 6 group A streptococci: net basic charge and intact Fc region. J Immunol (1983) 1.79
Regulation of virulence by environmental signals in group A streptococci: influence of osmolarity, temperature, gas exchange, and iron limitation on emm transcription. Infect Immun (1995) 1.78
Sequence and structural characteristics of the trypsin-resistant T6 surface protein of group A streptococci. J Bacteriol (1990) 1.78
Identification of an endogenous membrane anchor-cleaving enzyme for group A streptococcal M protein. Its implication for the attachment of surface proteins in gram-positive bacteria. J Exp Med (1989) 1.77
The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin. J Bacteriol (2001) 1.77
Glyceraldehyde-3-phosphate dehydrogenase on the surface of group A streptococci is also an ADP-ribosylating enzyme. Proc Natl Acad Sci U S A (1993) 1.76
Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells. J Clin Invest (1991) 1.73
Specific binding of the activator Mga to promoter sequences of the emm and scpA genes in the group A streptococcus. J Bacteriol (1995) 1.70
Presence of two distinct regions in the coiled-coil structure of the streptococcal Pep M5 protein: relationship to mammalian coiled-coil proteins and implications to its biological properties. Proc Natl Acad Sci U S A (1985) 1.68
Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia. Infect Immun (1997) 1.68
The IS1167 insertion sequence is a phylogenetically informative marker among isolates of serotype 6B Streptococcus pneumoniae. J Mol Evol (1998) 1.68
PspA and PspC: their potential for use as pneumococcal vaccines. Microb Drug Resist (1997) 1.67
The role of fibrinogen in staphylococcal adherence to catheters in vitro. J Infect Dis (1990) 1.64
Conformational characteristics of the complete sequence of group A streptococcal M6 protein. Proteins (1988) 1.62
Immunochemical analysis of intact M protein secreted from cell wall-less streptococci. Infect Immun (1981) 1.62
Spontaneous M6 protein size mutants of group A streptococci display variation in antigenic and opsonogenic epitopes. Proc Natl Acad Sci U S A (1988) 1.62